Lung cancer is the leading cause of cancer mortality in Western countries. It also provides an archetypal example of how inherited predisposing genetic variants may interact with an environmental infl...
This handbook is written to provide a 'bedside' reference for the practising oncologist, as well as a compendium of lung cancer information useful to thoracic surgeons, pulmonologists, respiratory med...
The future of lung cancer therapy appears to be heading towards regimens that will integrate surgery, chemotherapy, radiation, and in the not too distant future, immunotherapy, gene therapy, and other...
Written by highly eminent authors, Lung Cancer - a handbook in the Dana-Farber Cancer Institute series - is produced in full color and is richly illustrated throughout, providing a review of each can...
Oncology research and practice in lung cancer continues to develop rapidly, and this latest edition of "Lung Cancer Therapy Annual" briefs the oncology community with a review of the recent literature...
This well-established publication continues its unique round-up of the latest in research and practice in all aspects of lung cancer therapy. In a field that moves as quickly as oncological research a...
Lung cancer is the leading cause of cancer death in the United States, but IGRT (image guided radiation therapy) offers the possibility of more aggressive and enhanced treatments. The only available s...
This title presents chapters written by leading clinical researchers in the field of lung cancer, where high resolution 3-D imaging technology appears to hold the greatest near-term promise, as well a...
Alan B. Weitberg, MD, and a panel of internationally recognized basic scientists and clinicians present a comprehensive discussion of lung cancer, including a practice-oriented review of its diagnosi...